Publication & Citation Trends
Publications
0 total
Abstract HER2-18: HER2-18 Determination of HER2-low status in tumors of patients with unresectable and/or metastatic breast cancer in DESTINY-Breast04
Cited by 14
Semantic Scholar
Analytical and clinical validation of oncomine Dx target (ODxT) test and local testing for identifying patients with HER2 (ERBB2)-mutant (HER2m) non–small-cell lung cancer (NSCLC) for treatment with trastuzumab deruxtecan (T-DXd) in DESTINY-Lung01/02 (DL-01/02).
Cited by 0
Semantic Scholar
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer OA
Cited by 1,669
Semantic Scholar
Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer. OA
Cited by 659
Semantic Scholar
Reliable Gene Expression Profiling from Small and Hematoxylin and Eosin-Stained Clinical Formalin-Fixed, Paraffin-Embedded Specimens Using the HTG EdgeSeq Platform. OA
Cited by 20
Semantic Scholar
Changes in circulating tumor DNA levels are associated with treatment response and progression-free survival in relapse/refractory DLBCL subjects.
Cited by 1
Semantic Scholar
Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer. OA
Cited by 103
Semantic Scholar
Research Topics
Cancer Genomics and Diagnostics
(11)
Genomics and Rare Diseases
(10)
Lung Cancer Treatments and Mutations
(9)
Genomic variations and chromosomal abnormalities
(6)
HER2/EGFR in Cancer Research
(5)
Affiliations
GenVec
Inserm
Virginia Commonwealth University
Université de Montpellier
Université Paris Cité